Azenta (NASDAQ:AZTA) Announces Quarterly Earnings Results, Beats Estimates By $0.03 EPS

Azenta (NASDAQ:AZTA) released its quarterly earnings results on Wednesday. The company reported $0.08 EPS for the quarter, beating analysts’ consensus estimates of $0.05 by $0.03, Zacks reports. Azenta had a positive return on equity of 1.03% and a negative net margin of 25.01%.

Azenta Stock Performance

Shares of Azenta stock opened at $53.76 on Thursday. The stock’s 50-day moving average is $50.35 and its 200 day moving average is $49.07. Azenta has a one year low of $38.82 and a one year high of $67.77.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Needham & Company LLC lifted their price objective on Azenta from $55.00 to $59.00 and gave the stock a “buy” rating in a research note on Thursday. Stephens restated an “overweight” rating and issued a $60.00 price target on shares of Azenta in a research report on Thursday, January 2nd.

Insider Buying and Selling at Azenta

In related news, Director William L. Cornog purchased 12,500 shares of the firm’s stock in a transaction on Monday, November 18th. The stock was purchased at an average cost of $39.60 per share, with a total value of $495,000.00. Following the completion of the purchase, the director now owns 14,755 shares in the company, valued at approximately $584,298. This trade represents a 554.32 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO John Marotta acquired 12,717 shares of the business’s stock in a transaction dated Monday, November 18th. The shares were bought at an average cost of $39.48 per share, for a total transaction of $502,067.16. Following the transaction, the chief executive officer now directly owns 99,612 shares in the company, valued at approximately $3,932,681.76. This represents a 14.63 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have sold 1,423 shares of company stock valued at $57,020. 10.62% of the stock is currently owned by company insiders.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.